Pengyuan Leng, Ying Qiu, Mengxue Zhou, Yuhang Zhu, Na Yin, Mingming Zhou, Weili Wu, Min Liu
{"title":"甲状腺机能减退与骨质疏松症的相关性:脂质介质的潜在参与。","authors":"Pengyuan Leng, Ying Qiu, Mengxue Zhou, Yuhang Zhu, Na Yin, Mingming Zhou, Weili Wu, Min Liu","doi":"10.3389/fmed.2024.1453502","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Observational studies have demonstrated a correlation between thyroid dysfunction and osteoporosis (OP); however, the underlying causality has yet to be fully elucidated.</p><p><strong>Methods: </strong>The necessary dataset was sourced from public databases. Initially, instrumental variables (IVs) were selected based on three primary hypotheses. Subsequently, Cochran's Q test was employed to exclude IVs exhibiting heterogeneity. The MR-PRESSO test and the leave-one-out sensitivity test were further applied to detect potential pleiotropy. Inverse variance was utilized for the analysis. This study primarily utilized the inverse variance weighted (IVW) model for Mendelian analysis. Since Type 1 diabetes mellitus can also contribute to the development of osteoporosis, this study additionally employed multivariate Mendelian analysis. Furthermore, 249 circulating metabolites were selected for mediation analysis in the Mendelian randomization framework.</p><p><strong>Results: </strong>In this study, the two-sample Mendelian randomization (MR) analysis primarily employed the random-effects IVW model and demonstrated a causal relationship between hypothyroidism (OR = 1.092, 95% CI: 1.049-1.137, <i>p</i> < 0.001) and hyperthyroidism (OR = 1.080, 95% CI: 1.026-1.137, <i>p</i> = 0.003) with the risk of OP. No causal relationships were identified between FT3, FT4, TSH, and the risk of OP (<i>p</i> > 0.05). The results of the multivariate Mendelian randomization (MVMR) analysis indicated that hyperthyroidism was no longer a risk factor for OP (OR = 0.984, 95% CI: 0.918-1.055, <i>p</i> = 0.657), whereas hypothyroidism persisted as a risk factor (OR = 1.082, 95% CI: 1.021-1.147, <i>p</i> = 0.008). The mediated Mendelian randomization analysis revealed that hypothyroidism may exert an indirect effect on OP via triglycerides in large VLDL, mediating approximately 2.47% of the effect.</p><p><strong>Conclusion: </strong>This study identifies a potential link between hypothyroidism and OP, possibly mediated indirectly via triglyceride levels in large VLDL. Further investigations are required to elucidate the direct or indirect causal mechanisms underlying this association.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"11 ","pages":"1453502"},"PeriodicalIF":3.1000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565702/pdf/","citationCount":"0","resultStr":"{\"title\":\"Hypothyroidism correlates with osteoporosis: potential involvement of lipid mediators.\",\"authors\":\"Pengyuan Leng, Ying Qiu, Mengxue Zhou, Yuhang Zhu, Na Yin, Mingming Zhou, Weili Wu, Min Liu\",\"doi\":\"10.3389/fmed.2024.1453502\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Observational studies have demonstrated a correlation between thyroid dysfunction and osteoporosis (OP); however, the underlying causality has yet to be fully elucidated.</p><p><strong>Methods: </strong>The necessary dataset was sourced from public databases. Initially, instrumental variables (IVs) were selected based on three primary hypotheses. Subsequently, Cochran's Q test was employed to exclude IVs exhibiting heterogeneity. The MR-PRESSO test and the leave-one-out sensitivity test were further applied to detect potential pleiotropy. Inverse variance was utilized for the analysis. This study primarily utilized the inverse variance weighted (IVW) model for Mendelian analysis. Since Type 1 diabetes mellitus can also contribute to the development of osteoporosis, this study additionally employed multivariate Mendelian analysis. Furthermore, 249 circulating metabolites were selected for mediation analysis in the Mendelian randomization framework.</p><p><strong>Results: </strong>In this study, the two-sample Mendelian randomization (MR) analysis primarily employed the random-effects IVW model and demonstrated a causal relationship between hypothyroidism (OR = 1.092, 95% CI: 1.049-1.137, <i>p</i> < 0.001) and hyperthyroidism (OR = 1.080, 95% CI: 1.026-1.137, <i>p</i> = 0.003) with the risk of OP. No causal relationships were identified between FT3, FT4, TSH, and the risk of OP (<i>p</i> > 0.05). The results of the multivariate Mendelian randomization (MVMR) analysis indicated that hyperthyroidism was no longer a risk factor for OP (OR = 0.984, 95% CI: 0.918-1.055, <i>p</i> = 0.657), whereas hypothyroidism persisted as a risk factor (OR = 1.082, 95% CI: 1.021-1.147, <i>p</i> = 0.008). The mediated Mendelian randomization analysis revealed that hypothyroidism may exert an indirect effect on OP via triglycerides in large VLDL, mediating approximately 2.47% of the effect.</p><p><strong>Conclusion: </strong>This study identifies a potential link between hypothyroidism and OP, possibly mediated indirectly via triglyceride levels in large VLDL. Further investigations are required to elucidate the direct or indirect causal mechanisms underlying this association.</p>\",\"PeriodicalId\":12488,\"journal\":{\"name\":\"Frontiers in Medicine\",\"volume\":\"11 \",\"pages\":\"1453502\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11565702/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fmed.2024.1453502\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1453502","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:观察性研究表明,甲状腺功能障碍与骨质疏松症(OP)之间存在相关性,但其根本因果关系尚未完全阐明:方法:必要的数据集来自公共数据库。最初,根据三个主要假设选择了工具变量(IV)。随后,采用 Cochran's Q 检验排除表现出异质性的工具变量。此外,还采用了 MR-PRESSO 检验和留一敏感性检验来检测潜在的多向性。分析采用了逆方差分析。本研究主要采用逆方差加权(IVW)模型进行孟德尔分析。由于 1 型糖尿病也可能导致骨质疏松症,因此本研究还采用了多变量孟德尔分析法。此外,在孟德尔随机化框架下还选择了 249 种循环代谢物进行中介分析:在本研究中,双样本孟德尔随机化(MR)分析主要采用随机效应 IVW 模型,结果表明甲状腺功能减退(OR = 1.092,95% CI:1.049-1.137,P = 0.003)与 OP 风险之间存在因果关系。未发现 FT3、FT4、TSH 与 OP 风险之间存在因果关系(P > 0.05)。多变量孟德尔随机分析(MVMR)结果表明,甲状腺功能亢进不再是 OP 的风险因素(OR = 0.984,95% CI:0.918-1.055,p = 0.657),而甲状腺功能减退仍然是一个风险因素(OR = 1.082,95% CI:1.021-1.147,p = 0.008)。介导孟德尔随机分析显示,甲状腺机能减退可能通过大 VLDL 中的甘油三酯对 OP 产生间接影响,介导了约 2.47% 的影响:本研究确定了甲状腺功能减退症与 OP 之间的潜在联系,这种联系可能通过大 VLDL 中的甘油三酯水平间接介导。要阐明这种关联的直接或间接因果机制,还需要进一步的研究。
Hypothyroidism correlates with osteoporosis: potential involvement of lipid mediators.
Background: Observational studies have demonstrated a correlation between thyroid dysfunction and osteoporosis (OP); however, the underlying causality has yet to be fully elucidated.
Methods: The necessary dataset was sourced from public databases. Initially, instrumental variables (IVs) were selected based on three primary hypotheses. Subsequently, Cochran's Q test was employed to exclude IVs exhibiting heterogeneity. The MR-PRESSO test and the leave-one-out sensitivity test were further applied to detect potential pleiotropy. Inverse variance was utilized for the analysis. This study primarily utilized the inverse variance weighted (IVW) model for Mendelian analysis. Since Type 1 diabetes mellitus can also contribute to the development of osteoporosis, this study additionally employed multivariate Mendelian analysis. Furthermore, 249 circulating metabolites were selected for mediation analysis in the Mendelian randomization framework.
Results: In this study, the two-sample Mendelian randomization (MR) analysis primarily employed the random-effects IVW model and demonstrated a causal relationship between hypothyroidism (OR = 1.092, 95% CI: 1.049-1.137, p < 0.001) and hyperthyroidism (OR = 1.080, 95% CI: 1.026-1.137, p = 0.003) with the risk of OP. No causal relationships were identified between FT3, FT4, TSH, and the risk of OP (p > 0.05). The results of the multivariate Mendelian randomization (MVMR) analysis indicated that hyperthyroidism was no longer a risk factor for OP (OR = 0.984, 95% CI: 0.918-1.055, p = 0.657), whereas hypothyroidism persisted as a risk factor (OR = 1.082, 95% CI: 1.021-1.147, p = 0.008). The mediated Mendelian randomization analysis revealed that hypothyroidism may exert an indirect effect on OP via triglycerides in large VLDL, mediating approximately 2.47% of the effect.
Conclusion: This study identifies a potential link between hypothyroidism and OP, possibly mediated indirectly via triglyceride levels in large VLDL. Further investigations are required to elucidate the direct or indirect causal mechanisms underlying this association.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world